Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure

NCT07123506 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Atrial Flutter
Tachycardia, Supraventricular
Heart Septal Defects, Atrial

Interventions

DRUG: Beta-blocker treatment group
DRUG: Non-treatment group

Sponsor

Yonsei University